Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Zhang, Gao; Wu, Lawrence W; Mender, Ilgen; Barzily-Rokni, Michal; Hammond, Marc R; Ope, Omotayo; Cheng, Chaoran; Vasilopoulos, Themistoklis; Randell, Sergio; Sadek, Norah; Beroard, Aurelie; Xiao, Min; Tian, Tian; Tan, Jiufeng; Saeed, Umar; Sugarman, Eric; Krepler, Clemens; Brafford, Patricia; Sproesser, Katrin; Murugan, Sengottuvelan; Somasundaram, Rajasekharan; Garman, Bradley; Wubbenhorst, Bradley; Woo, Jonathan; Yin, Xiangfan; Liu, Qin; Frederick, Dennie T; Miao, Benchun; Xu, Wei; Karakousis, Giorgos C; Xu, Xiaowei; Schuchter, Lynn M; Mitchell, Tara C; Kwong, Lawrence N; Amaravadi, Ravi K; Lu, Yiling; Boland, Genevieve M; Wei, Zhi; Nathanson, Katherine; Herbig, Utz; Mills, Gordon B; Flaherty, Keith T; Herlyn, Meenhard; Shay, Jerry W.
Clin Cancer Res
; 24(19): 4771-4784, 2018 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-29563139
A Nonquiescent "Idling" Population State in Drug-Treated, BRAF-Mutated Melanoma.
Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Loss of IFN-Î³ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment.
Toward Minimal Residual Disease-Directed Therapy in Melanoma.
BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Codon-specific translation reprogramming promotes resistance to targeted therapy.
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.